TIS 0.00% 0.0¢ tissue therapies limited

August September, page-10

  1. 2,617 Posts.
    lightbulb Created with Sketch. 4
    Off to the side perhaps but biotechs back in favour in North America last week. TIS would certainly hit the right spot with any investor seeking exposure to this sector - post P3 and most commercialisation boxes ticked too.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.